Computational Modeling and Experimental Validation of Nitrile-Thiol Reactivity in Janus Kinase Inhibitors
RSC Medicinal Chemistry · 2026
DOI: 10.1039/d6md00709k ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Elaine Kim und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Despite their therapeutic potential and FDA approval for various autoimmune diseases, oral Janus kinase (JAK) inhibitors have been limited by systemic toxicities. We previously identified a reaction between the nitrile...
Zitieren
APA
Kim, E., Lee, Z., & Wang, L. (2026). Computational Modeling and Experimental Validation of Nitrile-Thiol Reactivity in Janus Kinase Inhibitors. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00709k
Vancouver
Kim E, Lee Z, Wang L. Computational Modeling and Experimental Validation of Nitrile-Thiol Reactivity in Janus Kinase Inhibitors. RSC Medicinal Chemistry. 2026. doi:10.1039/d6md00709k
BibTeX
@article{Kim2026,
author = {Kim, Elaine and Lee, Zheng-Chi and Wang, Leo},
title = {Computational Modeling and Experimental Validation of Nitrile-Thiol Reactivity in Janus Kinase Inhibitors},
journal = {RSC Medicinal Chemistry},
year = {2026},
doi = {10.1039/d6md00709k}
}
EUVIMED